The Exceptional Responders Initiative: Welcoming More Cases



The initiative is studying tissue, clinical, and genomic data from patients with cancer who have had dramatic and long-lasting responses to standard and experimental treatments that were not seen in similar patients who received the same treatment.



Source link

Comments are closed.